Cytophage Technologies (TSXV:CYTO) Marketable Securities : C$5.43 Mil (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Cytophage Technologies's Marketable Securities for the quarter that ended in Dec. 2023 was C$5.43 Mil.

Cytophage Technologies's annual Marketable Securities stayed the same from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.00 Mil) but then increased from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$5.43 Mil).

Cytophage Technologies Marketable Securities Historical Data

The historical data trend for Cytophage Technologies's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Marketable Securities Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Marketable Securities

5.43

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Sep23	Dec23
Marketable Securities	-	-	-	-	5.43

Cytophage Technologies Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Cytophage Technologies (TSXV:CYTO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Cytophage Technologies Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.